Search research articles
Contact Us
Filters
Showing results (11-20 of 329) with videos related to
Page
of 33
Sort By:
Journal of Thrombosis and Thrombolysis
|
June 10, 2026
Advancing cancer therapeutics: new perspectives on mechanisms, regulatory and policy challenges, and innovative multi-modality strategies for the early detection of cardiotoxicity
Richard C Becker
Journal of Thrombosis and Thrombolysis
|
January 27, 2021
COVID-19 and its sequelae: a platform for optimal patient care, discovery and training
Richard C Becker
Texas Heart Institute Journal
|
January 6, 2006
COX-2 inhibitors
Richard C Becker
Current Cardiology Reports
|
June 8, 2002
Choice of agents to limit the coagulation cascade in acute coronary syndromes
Richard C Becker
Journal of Thrombosis and Thrombolysis
|
April 13, 2023
Evaluating chest pain in patients with post COVID conditions permission to think outside of the box
Richard C Becker
Journal of Thrombosis and Thrombolysis
|
July 24, 2020
COVID-19-associated vasculitis and vasculopathy
Richard C Becker
Journal of Thrombosis and Thrombolysis
|
May 15, 2021
Factor Xa inhibitors: critical considerations for clinical development and testing
Richard C Becker
Journal of Thrombosis and Thrombolysis
|
May 29, 2026
Regulatory challenges and current policy for cardiotoxicity detection in oncology drug development
Richard C Becker
Journal of Thrombosis and Thrombolysis
|
January 8, 2016
Aspirin dosing frequency in the primary and secondary prevention of cardiovascular events
Joonseok Kim, Richard C Becker
Journal of Thrombosis and Thrombolysis
|
October 22, 2008
Anticoagulant therapy during cardiopulmonary bypass
Maryam Yavari, Richard C Becker
Page
of 33
Search research articles
Search
Showing results (11-20 of 329) with videos related to
Sort By:
Page
of 33
Journal of Thrombosis and Thrombolysis
|
June 10, 2026
Advancing cancer therapeutics: new perspectives on mechanisms, regulatory and policy challenges, and innovative multi-modality strategies for the early detection of cardiotoxicity
Richard C Becker
Journal of Thrombosis and Thrombolysis
|
January 27, 2021
COVID-19 and its sequelae: a platform for optimal patient care, discovery and training
Richard C Becker
Texas Heart Institute Journal
|
January 6, 2006
COX-2 inhibitors
Richard C Becker
Current Cardiology Reports
|
June 8, 2002
Choice of agents to limit the coagulation cascade in acute coronary syndromes
Richard C Becker
Journal of Thrombosis and Thrombolysis
|
April 13, 2023
Evaluating chest pain in patients with post COVID conditions permission to think outside of the box
Richard C Becker
Journal of Thrombosis and Thrombolysis
|
July 24, 2020
COVID-19-associated vasculitis and vasculopathy
Richard C Becker
Journal of Thrombosis and Thrombolysis
|
May 15, 2021
Factor Xa inhibitors: critical considerations for clinical development and testing
Richard C Becker
Journal of Thrombosis and Thrombolysis
|
May 29, 2026
Regulatory challenges and current policy for cardiotoxicity detection in oncology drug development
Richard C Becker
Journal of Thrombosis and Thrombolysis
|
January 8, 2016
Aspirin dosing frequency in the primary and secondary prevention of cardiovascular events
Joonseok Kim, Richard C Becker
Journal of Thrombosis and Thrombolysis
|
October 22, 2008
Anticoagulant therapy during cardiopulmonary bypass
Maryam Yavari, Richard C Becker
Page
of 33